Document is current
Any future updates will be listed below
-
Authors
Park, Sangjoon
Kim, Hojin
Wee, Chan Woo
Kim, Young Seok
Choi, Jin Hwa
Kim, Yeon Sil
Lee, Jong Hoon
Choi, Youngmin
Kim, Jin Hee
Cho, Yeona
Kim, Hyun Ju
Park, Young Je
Park, Won
Eom, Keun-Yong
Kim, Yun Hwan
Kim, Yong Bae
-
Funding
Funding for this research was provided by:
Ministry of Health and Welfare (HA22C0021)
- License Information
-
More Information
Article History
Received: 4 July 2024
Accepted: 10 March 2025
First Online: 18 August 2025
Declarations
:
: The protocol for the SABR-ROC trial received approval from multiple boards: the Institutional Review Board of Severance Hospital, Yonsei University College of Medicine in Seoul, Republic of Korea (4-2022-0286) on April 7, 2022; the Scientific Review Board of KGOG (3064) on April 25, 2022; and the Protocol Review Board of KROG (2204) on July 12, 2022. All clinical treatments adhere to the International Good Clinical Practice Guidelines and the Declaration of Helsinki. Informed consent was waived due to the retrospective nature of this dummy-run study.
: Not applicable.
: The authors declare no competing interests.
